Bone Biologics Corp (BBLG)
1.465
-0.14
(-8.44%)
USD |
NASDAQ |
Apr 24, 16:00
1.465
0.00 (0.00%)
After-Hours: 17:10
Bone Biologics Shareholders Equity (Quarterly): 2.906M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.906M |
| September 30, 2023 | 3.793M |
| June 30, 2023 | 5.693M |
| March 31, 2023 | 2.772M |
| December 31, 2022 | 5.947M |
| September 30, 2022 | 4.402M |
| June 30, 2022 | 5.588M |
| March 31, 2022 | 6.039M |
| December 31, 2021 | 6.576M |
| September 30, 2021 | -15.13M |
| June 30, 2021 | -14.62M |
| March 31, 2021 | -14.12M |
| December 31, 2020 | -13.69M |
| September 30, 2020 | -13.24M |
| June 30, 2020 | -12.84M |
| March 31, 2020 | -12.46M |
| December 31, 2019 | -11.87M |
| Date | Value |
|---|---|
| September 30, 2019 | -11.38M |
| June 30, 2019 | -10.86M |
| March 31, 2019 | -9.972M |
| December 31, 2018 | -8.598M |
| September 30, 2018 | -7.174M |
| June 30, 2018 | -9.456M |
| March 31, 2018 | -8.534M |
| December 31, 2017 | -8.396M |
| September 30, 2017 | -10.90M |
| June 30, 2017 | -10.25M |
| March 31, 2017 | -8.270M |
| December 31, 2016 | -8.364M |
| September 30, 2016 | -7.050M |
| June 30, 2016 | -5.316M |
| March 31, 2016 | -3.012M |
| December 31, 2015 | -5.681M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-15.13M
Minimum
Sep 2021
6.576M
Maximum
Dec 2021
-4.552M
Average
-10.86M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
| BioVie Inc | 7.491M |
| Krystal Biotech Inc | 778.64M |
| Adial Pharmaceuticals Inc | 4.084M |
| Processa Pharmaceuticals Inc | 4.989M |
| Calidi Biotherapeutics Inc | -8.235M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.738M |
| Total Liabilities (Quarterly) | 0.8314M |